Pharma, patient advocates clash over Inflation Reduction Act
Pharmaceutical Technology
MAY 17, 2023
At a lively panel at Financial Times US Pharma and Biotech Summit on May 16, panellists were at odds over whether the new legislation would improve treatment affordability or stifle pharma innovation. Meanwhile, the pharma industry is contending with a tough economic climate and a series of inflationary and supply chain pressures.
Let's personalize your content